Alzheimer's Drugs May Be a Big-Pharma Payday. Lilly and Biogen Are Facing Off.
Two similar Alzheimer’s drugs are likely to be on the market and accessible for Medicare patients sometime in 2024.
Source: marketwatch.com
Stay updated with breaking news from Marck Mintun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two similar Alzheimer’s drugs are likely to be on the market and accessible for Medicare patients sometime in 2024.